When Wendy Clift went for a routine breast scan in 2007, she got call from her doctors almost immediately.
Share this @internewscast.com

When Wendy Clift went for a routine breast scan in 2007, she got call from her doctors almost immediately.

“The news wasn’t good,” the widowed grandmother of two from Scone in regional NSW told 9news.com.au.

When Wendy Clift went for a routine breast scan in 2007, she got call from her doctors almost immediately.
Wendy Clift was diagnosed with breast cancer in 2007. (Supplied)

Just days later, she had a mastectomy, followed by more treatment.

While it was successful in keeping her in remission for a few years, the cancer has now returned and it has spread.

However, Clift, now 72, was invited to be part of a new Australian drug trial.

It’s hoped it could help patients with a certain kind of breast cancer live longer.

The DIAmOND clinical trial indicated that introducing dual immunotherapy alongside existing treatments might be beneficial for some patients suffering from advanced HER2-positive breast cancer.

Clift said her cancer appears to be “pretty stable” after the trial earlier this year, which she did at Lake Macquarie Private Hospital.

Some of the cancerous lumps she had have even disappeared, though she doesn’t know if that’s due to the new drug combination.

Clift said she didn’t have side effects.

She said taking part in the trial was less about her and more to help future patients.

“I’m just prepared because whatever happens to me is neither here nor there, but hopefully in years to come it’ll help somebody else,” she said.

Immunotherapy is a treatment that uses a person’s immune system to treat certain cancers.

When Wendy Clift went for a routine breast scan in 2007, she got call from her doctors almost immediately.
Wendy Clift, pictured with son Joshua and grandchildren Florence and Arthur, says she just wants to help future cancer patients. (Supplied)

The other drug used alongside this in the trial was trastuzumab, commonly known as Herceptin.

The trial focused on determining whether the combination could extend the period during which cancer remained controlled in patients with advanced conditions that had developed resistance to trastuzumab.

Results differed depending on the kind of cancer each of the 68 trial patients had.

Some had a response rate of up to 63 per cent, while for other kinds it was 27 per cent.

Some patients saw their cancer controlled for more than two years.

The combination of drugs has been given previously to people with lung cancer.

Professor Sherene Loi developed and led the trial, which was conducted by the research organisation Breast Cancer Trials.

“The encouraging findings imply that pairing new immunotherapy treatments with trastuzumab could provide a new treatment avenue for those with treatment-resistant HER2-positive breast cancer,” Loi stated.

“These findings provide a compelling case for further exploration and how we can best integrate this treatment combination into clinical practice.”

What is HER2-positive breast cancer?

HER2-positive breast cancer is a type of breast cancer that tests positive for a protein called human epidermal growth factor receptor 2 (HER2).

However, it often responds well to specific treatments.

Around 15-20 per cent of all types of breast cancers are HER2-positive.

It is more common in younger, pre-menopausal women.

Share this @internewscast.com
You May Also Like

Australia’s Blessing Scams: 80 Incidents, $3 Million Lost, and New Allegations

A 62-year-old man has been charged as part of an investigation into…

Potential RBA Interest Rate Reduction: Implications for Australian Homeowners

The Reserve Bank of Australia is set to convene today, with most…
Mt Hotham locals woke to more than 10cm of fresh snow this morning after temperatures plunged to almost minus four degrees.

Strong Cold Front to Bring Up to 40cm of Snow to Mountain Areas

Australia’s alpine resorts are forecasting the best July snow conditions in recent…
Storm weather. Torrential rain

Do you trust the “feels like” temperature or the real one? Here’s the explanation

Between ‘bomb cyclones’ and polar blasts, many Aussies have been shivering through…

Tadej Pogacar Secures Milestone 100th Career Victory in Tour de France Stage Four Triumph

Slovenian cyclist Tadej Pogacar surged past his competitors in a spectacular finish…
Small business owners react to RBA decision

Cafe and Pub Owners Face Challenges Following Interest Rate Change

According to data from Creditor Watch, 10% of hospitality businesses have shuttered…
ChatGPT, Bing and Google apps on an Apple iPhone.

Why Some Young Australians Avoid AI: The Reason Behind This Photo

Some young Australians are choosing not to use trending generative AI tools…

US Eliminates Shoe Removal at Airport Screenings After 20 Years

Passengers at United States airports will no longer have to remove their…
Erin Patterson is on trial accused of three counts of murder and one of attempted murder.

Chronology of Key Events Leading to Erin Patterson’s Conviction

Erin Patterson has ultimately been declared guilty of three counts of murder…

Sussan Ley Urges Anthony Albanese to Implement Anti-Antisemitism Strategy

Opposition leader Sussan Ley is calling on the Albanese government to implement…
South Island giant moa.

Oscar Winner’s Ambition Sparks Efforts to Revive the Extinct Moa

An acclaimed filmmaker’s grumble could be the catalyst that brings a centuries-extinct…
Authorities say the spread shouldn't impact the nearby dolphin sanctuary, as the state government announces fee relief for affected fishers.

Harmful Algae Bloom Threatens Dolphin Sanctuary Nearby

The algal bloom devastating South Australian marine life has now been found…